F2,6BP restores mitochondrial genome integrity in Huntington’s disease
Journal of Biological Chemistry · 2026
DOI: 10.1016/j.jbc.2026.111156 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026. Verfasst von Anirban Chakraborty und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA. Hauptthemen laut MEDLINE: Huntington Disease, Genome, Mitochondrial. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, National Institute on Aging, Alzheimer's Association.
Abstract (Originalsprache)
Several reports have indicated that impaired mitochondrial function contributes to the development and progression of Huntington's disease (HD). Mitochondrial genome damage, particularly DNA strand breaks, is a potential cause for its compromised functionality. Here we show that the activity of polynucleotide kinase 3'-phosphatase (PNKP), a critical DNA end-processing enzyme, is significantly decreased in the mitochondrial extract of brains of patients with HD due to a lower level of fructose-2,6 bisphosphate (F2,6BP), a biosynthetic product of 6-phosphofructo-2-kinase fructose-2,6-bisphosphatase 3 (PFKFB3). Such decrease in PNKP activity leads to persistent DNA strand breaks that are refractory to subsequent steps for repair completion. Both PFKFB3 and F2,6BP, an allosteric modulator of glycolysis, are also present in the mitochondria, and PFKFB3 is part of a mitochondrial DNA repair complex containing HTT, PNKP, DNA Pol γ (POLG), and Lig IIIα. Notably, PNKP binds F2,6BP (Kd = 525 ± 25 nM) and utilizes it as a cofactor. The levels of both F2,6BP and PFKFB3 are significantly decreased in the mitochondrial extract of HD mouse striatal neuronal cells and patients' brain. Activity of PNKP is thus severely decreased in the mitochondrial extract; however, addition of F2,6BP restored its activity. Moreover, supplementation of F2,6BP in HD cells restored PFKFB3 level, mitochondrial genome integrity and partially restored mitochondrial membrane potential, mitochondrial respiration and prevented pathogenic aggregate formation. Importantly, F2,6BP supplementation significantly restored mitochondrial genome integrity in an HD Drosophila model. Our findings, therefore, suggest that F2,6BP-mediated restoration of PNKP activity could have a profound impact in ameliorating neurodegenerative symptoms in HD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA.
- Department of Chemistry and Biochemistry, University of California San Diego, LA Jolla, California, USA.
- Department of Oncology, University of Alberta and Cross Cancer Institute, Edmonton, Alberta, Canada.
- Department of Neurosurgery, Center for Neuroregeneration, The Houston Methodist Research Institute, Houston, Texas, USA.
- Department of Neurology, University of Texas Medical Branch, Galveston, Texas, USA.
- Center for Bioenergetics, Charles W. Duncan Jr. Department of Medicine, The Houston Methodist Research Institute, Houston, Texas, USA.
Förderung
- NINDS NIH HHS
- National Institute on Aging
- Alzheimer's Association
- National Institutes of Health
- University of Texas Medical Branch
- University of Alberta
Zitieren
APA
Chakraborty, A., Mandal, S. M., Mankevich, M., Mani, R. S., Shahabi, S., Kodavati, M., Sreenivasmurthy, S. G., Tapryal, N., Hamilton, D. J., Krishnan, B., Hegde, M. L., Weinfeld, M., Ghosh, G., & Hazra, T. (2026). F2,6BP restores mitochondrial genome integrity in Huntington’s disease. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2026.111156
Vancouver
Chakraborty A, Mandal SM, Mankevich M, Mani RS, Shahabi S, Kodavati M, et al. F2,6BP restores mitochondrial genome integrity in Huntington’s disease. Journal of Biological Chemistry. 2026. doi:10.1016/j.jbc.2026.111156
BibTeX
@article{Chakraborty2026,
author = {Chakraborty, Anirban and Mandal, Santi M and Mankevich, Mikita and Mani, Rajam S and Shahabi, Shandy and Kodavati, Manohar and Sreenivasmurthy, Sravan Gopalkrishnashetty and Tapryal, Nisha and Hamilton, Dale J and Krishnan, Balaji and Hegde, Muralidhar L and Weinfeld, Michael and Ghosh, Gourisankar and Hazra, Tapas},
title = {F2,6BP restores mitochondrial genome integrity in Huntington’s disease},
journal = {Journal of Biological Chemistry},
year = {2026},
doi = {10.1016/j.jbc.2026.111156}
}
EUVIMED